Race to find better prep for Life-Saving transplants
NCT ID NCT01366612
Summary
This study compared two different drug combinations given to patients before they received a stem cell transplant from a donor. The goal was to see which combination better prevented the cancer from returning while causing fewer side effects. The trial involved adults with certain blood cancers like leukemia and was stopped early after enrolling 53 of the planned 80 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
Conditions
Explore the condition pages connected to this study.